Meiya Optoelectronic 2025 Annual Report: Medical Equipment Business Revenue of 454 Million Yuan, Down 9.75% Year-on-Year

Image Source: Meiya Optoelectronic 2025 Annual Report

Annual Revenue: 2.407 Billion CNY / Annual Net Profit Attributable to Shareholders of the Parent Company: 719 Million CNY / Annual Non-GAAP Net Profit: 707 Million CNY

DentalGoodNews | On March 31, 2026, Meiya Optoelectronic (002690) released its 2025 annual report. During the reporting period, the company achieved operating revenue of 2.407 billion CNY, a year-on-year increase of 4.16%; net profit attributable to shareholders of the listed company was 719 million CNY, a year-on-year increase of 10.77%; net profit attributable to shareholders of the parent company excluding non-recurring items was 707 million CNY, a year-on-year increase of 12.55%. Net cash flow from operating activities was 962 million CNY, a year-on-year increase of 9.62%, indicating a simultaneous improvement in profit quality. In the fourth quarter, the company achieved revenue of 713 million CNY, net profit attributable to shareholders of the parent company of 200 million CNY, and net profit attributable to shareholders of the parent company excluding non-recurring items of 198 million CNY.

Regarding the medical equipment business, revenue in 2025 was 454 million CNY, a year-on-year decrease of 9.75%, accounting for 18.87% of total revenue. The company noted in its financial report that the domestic dental industry is still in a phased trough period, with market demand declining due to macroeconomic and industry-specific factors. However, the company maintains an optimistic outlook for long-term development.

Furthermore, the announcement indicated that during the reporting period, the company launched the industry's first dental imaging intelligent agent, "Meiya Imaging Engine," and introduced a matrix of products including the MyScan5 intraoral scanning intelligent agent, promoting the transformation of dental diagnosis and treatment from "single-point tools" to "collective intelligence." Simultaneously, the company stated that its "Meiya Dental" oral health digital cloud platform has accumulated over 10,000 dental institution users.

Image Source: Meiya Optoelectronic 2025 Annual Report

According to the financial report, the proportion of direct sales increased to 70.47%, a year-on-year growth of 14.10%; performance in overseas markets remained stable, with overseas revenue in 2025 reaching 564 million CNY, a year-on-year increase of 9.78%, raising its share to 23.42%. The company is promoting the simultaneous expansion of medical equipment and color sorters into overseas markets by establishing overseas branches and optimizing sales strategies.

Image Source: Meiya Optoelectronic 2025 Annual Report

In terms of expenses, the company's R&D expenses in 2025 were 164 million CNY, a year-on-year increase of 2.80%, accounting for 6.81% of operating revenue; sales expenses were 296 million CNY, a year-on-year increase of 0.74%, remaining generally stable; administrative expenses were 102 million CNY, a year-on-year decrease of 7.73%. Regarding assets and cash flow, as of the end of 2025, the company's total assets were 3.608 billion CNY, a year-on-year increase of 8.10%; net cash flow generated from operating activities was 962 million CNY, a year-on-year increase of 9.62%.

Image Source: Meiya Optoelectronic 2025 Annual Report

Additionally, the company plans to distribute cash dividends based on the total number of shares of 882,228,900 as of February 28, 2026, allocating RMB 7.00 per 10 shares (tax inclusive) to all shareholders, totaling cash dividends of 617,560,230.00 CNY. The remaining undistributed profits will be carried forward for future distribution, with no bonus shares issued and no conversion of capital reserve into share capital. Regarding legal disputes, according to a previous report by DGN, the Supreme People's Court issued a final judgment in January 2026 on Meiya Optoelectronic's lawsuit against Dentalfly for trade secret infringement, ordering Dentalfly to compensate Meiya Optoelectronic for economic losses of 198 million CNY.